Briefings for the people who sign off on healthcare AI
What changed in the rules, how to judge a category of vendor before anyone books a demo, and how a rollout is actually run once the contract is signed. Every piece is written by a consultant and reviewed before it goes up. Start with the group that matches the question you came with.
Regulatory change
What moved in the rules, and what it asks of a provider.
CMS-0057-F: What Provider Organizations Should Do This Quarter
The prior authorization rule binds payers, not providers. Here is what a provider organization should do this quarter to be ready for the January 2027 APIs.
10 min readClunic Research Team
What Changed in Healthcare AI Regulation in 2026
What actually moved in US healthcare AI regulation in 2026: the ONC certification rewrite, CMS prior authorization deadlines, FDA guidance and four state laws.
10 min readClunic Research Team
The State AI Law Map: A Multi-State Compliance Strategy for Providers
Colorado, California, Utah and Texas regulate healthcare AI differently. A comparison table and a comply-with-the-strictest framework for multi-state groups.
11 min readClunic Research Team
Buyer guides
How to evaluate a category before anyone books a demo.
Define the Metrics Before the Pilot, Not After It
How to define success metrics before an AI agent pilot: baselines, adoption versus outcome measures, time to value, and the stopping rule that kills it early.
10 min readClunic Research Team
Buying an AI Scribe With Fewer Than Ten Providers
How practices with under ten providers should buy an ambient AI scribe: self-serve versus enterprise, real pricing, a four week pilot, and contract red flags.
10 min readClunic Research Team
EHR Integration Due Diligence: The Questions That Decide the Timeline
FHIR versus proprietary APIs, app store listings, sandbox access and who pays the fee: the integration questions to ask an AI vendor before you sign anything.
11 min readClunic Research Team
The HIPAA Checklist to Send Before You Book an AI Scribe Demo
Twenty questions to send an AI scribe vendor before the demo, covering business associate agreements, retention, model training, consent and offboarding.
14 min readClunic Research Team
Fifteen Security Questions Every Healthcare AI RFP Should Contain
Fifteen security and compliance questions for any healthcare AI RFP, what a good answer sounds like, and the BAA scope traps that catch buyers after signature.
11 min readClunic Research Team
Playbooks
How the work is actually run, step by step.
The AI Acceptable Use Policy a Medical Practice Can Actually Enforce
A section by section AI acceptable use policy for medical practices: approved tools, what staff may paste, PHI rules, incident reporting and enforcement.
12 min readClunic Research Team
Nobody Is Using It: The Clinician AI Adoption Playbook for After Go Live
How to drive clinician AI adoption after launch: champion models, note quality feedback loops, measuring real usage against licensed seats, why mandates fail.
11 min readClunic Research Team
The AI Governance Committee That Ships Decisions Instead of Blocking Them
A working charter, membership list, intake form, risk tiers and meeting cadence for a hospital AI governance committee, mapped to the NIST AI RMF.
11 min readClunic Research Team
Analysis
Where the market is going, and which claims stopped being true.
Agent, Copilot or Automation: The Distinction That Decides Your Governance
What an AI agent actually is in healthcare, how it differs from a copilot and from RPA, and why the distinction changes the controls you are obliged to build.
12 min readClunic Research Team
Build or Buy: The Real Math on In House Healthcare AI Agents
The platform, talent and liability math behind building AI agents in house, a total cost of ownership comparison, and the narrow cases where building wins.
12 min readClunic Research Team
Pajama Time: What the Documentation Burden Evidence Actually Says
What the published studies on physician documentation time and after hours EHR work really show, what they do not, and where AI scribe vendors overreach.
13 min readClunic Research Team
The Pilot Worked. Why Did Nothing Reach Production?
Integration debt, missing baselines, governance gaps and incentive misalignment: the four reasons healthcare AI pilots stall, and the method that avoids them.
12 min readClunic Research Team
Find the piece for where you are
Most readers land here with a specific job in front of them, not a craving for the newest post. Pick the paragraph that matches it.
Choosing: nothing is signed yet
The job is separating a vendor from its demo. Fifteen security and compliance questions belong in any RFP for a tool that will touch protected health information, and a shorter checklist for a scribe vendor specifically narrows that list to what should already be documented before the call. Running fewer than ten providers changes the answer: buying at that size means the self-serve end of the market and a monthly term, not an enterprise sales process built for a health system. the integration questions that decide the timeline cover which API a vendor actually uses to read and write, which is the detail that turns a two week go-live into a two month one. And before any of that, the build-versus-buy math names the narrow set of organisations for whom building is genuinely the right call.
Deploying: the contract is signed
Define the metrics before the pilot starts, not after: a baseline held for two weeks, one outcome metric that would justify the spend, and a stopping rule written down while everyone is still being reasonable. Knowing whether the thing you bought is an agent, a copilot or plain automation matters at the same stage, because that distinction is what decides the controls the rollout needs, not the vendor’s marketing name for it. And once it is live, adoption is won or lost in the eight weeks after go-live, with a champion model and a note quality feedback loop doing more than a mandate ever does.
Governing: more than one tool is live
A governance committee earns its place by returning decisions on a clock: a written charter, a named decision owner, and risk tiers that give a low-stakes tool a lighter review than a high-stakes one. A smaller practice rarely needs a committee at all; a two-page acceptable use policy covers approved tools, what staff may never paste into an unapproved one, and who reviews AI-drafted output before it is used. On the regulatory side, a year-by-year account of what actually moved tracks ONC, CMS and FDA in one place, a comparison of the state AI laws with healthcare duties covers a group operating across state lines, and the CMS-0057-F provider checklist turns a rule that binds payers, not providers, into the handful of things a provider organisation should actually check this quarter.
Fixing something that already went wrong
Sometimes the question is not what to buy or how to run it, but why a live tool is not working, or why a number being quoted in a meeting does not hold up. Pilots rarely stall because the model was bad: integration work that got deferred, a baseline nobody captured, and no governance route from pilot to production do most of the damage. The evidence behind the documentation burden numbers is narrower than the marketing built on top of it, and this piece says exactly where the two studies carrying most of that weight stop supporting the claim.
How these briefings are put together
Every piece here is written by the same research team that maintains the use case, EHR and regulation pages on this site, against sources it names rather than a vendor’s own claims. Each post carries a list of the sources it draws on and the date it was last checked, the same discipline the rest of the site runs on.
We take no commission, referral fee or paid placement from any vendor named in these posts, and no comparison or ranking here is sponsored. Where the evidence for a claim is thinner than the marketing around it, the piece says so, rather than repeating a number nobody can source. The full commitment, and the route to flag something that needs correcting, is on our editorial policy page.
Know what changed before your vendor tells you
A monthly regulatory and vendor intelligence note for people who have to sign off on this. What moved in HIPAA, ONC and state AI rules, and which vendor claims stopped being true.
Book an evaluation call at any point. No obligation.